EUVIMEDEUVIMED entdecken
Open Access

Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies

Feixue Wei iD, Marc T Goodman, Ningshao Xia iD, Jun Zhang iD, Anna R Giuliano, Gypsyamber D'Souza, Nancy A Hessol, Maarten F Schim van der Loeff, Jianghong Dai, Karin Neukam iD, Alexandra de Pokomandy, I Mary Poynten und 26 weitere

Clinical Infectious Diseases · 2023

DOI: 10.1093/cid/ciac581 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2023. Verfasst von Feixue Wei und 37 weiteren Autor:innen. Beteiligte Einrichtung: Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. Hauptthemen laut MEDLINE: Papillomavirus Infections, HIV Infections, Sexual and Gender Minorities, Anus Diseases. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: World Health Organization, NCI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding the natural history of anal high-risk human papillomavirus (hrHPV) infection is key for designing anal cancer prevention programs but has not been systematically characterized.

Methods

We reanalyzed data from 34 studies including 16 164 individuals in 6 risk groups defined by human immunodeficiency virus (HIV) status, sex, and male sexuality: men who have sex with men (MSM) and people with HIV (MSMWH), HIV-negative MSM, women with HIV (WWH), HIV-negative women, men who have sex with women (MSW) with HIV (MSWWH), and HIV-negative MSW. We used Markov models to estimate incidence and clearance of 13 hrHPV types and their determinants.

Results

Human papillomavirus (HPV) 16 had the highest incidence-clearance ratio of the hrHPV types. MSMWH had the highest hrHPV incidence (eg, 15.5% newly HPV-16 infected within 2 years), followed by HIV-negative MSM (7.5%), WWH (6.6%), HIV-negative women (2.9%), MSWWH (1.7%), and HIV-negative MSW (0.7%). Determinants of HPV-16 incidence included HIV status and number of sexual partners for MSM, women, and MSW, and anal sex behavior for MSM only. HPV-16 clearance was lower for people with HIV (PWH) and lower for prevalent than incident infection. Among MSM, increasing age was associated with lower clearance of prevalent, but not incident, HPV-16 infection.

Conclusions

This robust and unifying analysis of anal hrHPV natural history is essential to designing and predicting the impact of HPV vaccination and HPV-based screening programs on anal cancer prevention, particularly in MSM and PWH. Importantly, it demonstrates the higher carcinogenic potential of longstanding anal prevalent hrHPV infection than more recent incident infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus InfectionsHIV InfectionsSexual and Gender MinoritiesAnus DiseasesAnus NeoplasmsMaleHumansFemaleHomosexuality, MaleHuman Papillomavirus VirusesIncidenceSexual BehaviorAnal CanalLongitudinal StudiesHuman papillomavirus 16HIVPapillomaviridae

Stichwörter der Autor:innen

HIVHPVanusclearanceincidence

Autor:innen und Institutionen

  • Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Cancer Prevention and Control Program, Cedars Cancer, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, Fujian, Chin…
  • Center for Immunization and Infection Research in Cancer (CIIRC), Moffitt Cancer Center, Tampa, Florida, USA.
  • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Department of Clinical Pharmacy, University of California San Francisco, California, USA.

ORCID-Profile: Feixue Wei, Ningshao Xia, Jun Zhang, Karin Neukam, Gary M Clifford

Förderung

  • World Health Organization
  • NCI NIH HHS
  • NIH

Zitieren

APA

Wei, F., Goodman, M. T., Xia, N., Zhang, J., Giuliano, A. R., D'Souza, G., Hessol, N. A., Schim van der Loeff, M. F., Dai, J., Neukam, K., de Pokomandy, A., Poynten, I. M., Geskus, R. B., Burgos, J., Etienney, I., Moscicki, A. B., Donà, M. G., Gillison, M. L., Nyitray, A. G., …, & Clifford, G. M. (2023). Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciac581

Vancouver

Wei F, Goodman MT, Xia N, Zhang J, Giuliano AR, D'Souza G, et al. Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies. Clinical Infectious Diseases. 2023. doi:10.1093/cid/ciac581

BibTeX
@article{Wei2023,
  author = {Wei, Feixue and Goodman, Marc T and Xia, Ningshao and Zhang, Jun and Giuliano, Anna R and D'Souza, Gypsyamber and Hessol, Nancy A and Schim van der Loeff, Maarten F and Dai, Jianghong and Neukam, Karin and de Pokomandy, Alexandra and Poynten, I Mary and Geskus, Ronald B and Burgos, Joaquin and Etienney, Isabelle and Moscicki, Anna-Barbara and Donà, Maria Gabriella and Gillison, Maura L and Nyitray, Alan G and Nowak, Rebecca G and Yunihastuti, Evy and Zou, Huachun and Hidalgo-Tenorio, Carmen and Phanuphak, Nittaya and Molina, Jean-Michel and Schofield, Alice M and Kerr, Stephen and Fan, Song and Lu, Yong and Ong, Jason J and Chikandiwa, Admire T and Teeraananchai, Sirinya and Squillace, Nicola and Wiley, Dorothy J and Palefsky, Joel M and Georges, Damien and Alberts, Catharina J and Clifford, Gary M},
  title = {Incidence and Clearance of Anal Human Papillomavirus Infection in 16 164 Individuals, According to Human Immunodeficiency Virus Status, Sex, and Male Sexuality: An International Pooled Analysis of 34 Longitudinal Studies},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  doi = {10.1093/cid/ciac581}
}
Kostenlos starten →